Evidence map›Paper›PMID 38165906›Full record

ArticlePloS one2024

Feasibility and acceptability of SEPA+PrEP: An HIV prevention intervention to increase PrEP knowledge, initiation, and persistence among cisgender heterosexual Hispanic women.

Rosina Cianelli, Joseph P De Santis, Giovanna C De Oliveira, Jose G Castro, Evelyn Iriarte, María José Baeza, Sophia O Thomas, Natalia Villegas, Nilda Peragallo-Montano

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rosina CianelliSchool of Nursing and Health Studies, University of Miami, Coral Gables, Florida, United States of America.ORCID 0000-0002-4294-5569
Joseph P De SantisSchool of Nursing and Health Studies, University of Miami, Coral Gables, Florida, United States of America.
Giovanna C De OliveiraSchool of Nursing and Health Studies, University of Miami, Coral Gables, Florida, United States of America.
Jose G CastroMiller School of Medicine, University of Miami, Miami, Florida, United States of America.
Evelyn IriarteEscuela de Enfermería, Pontificia Universidad Católica de Chile, Santiago, Chile.
María José BaezaSchool of Nursing and Health Studies, University of Miami, Coral Gables, Florida, United States of America.ORCID 0000-0001-8594-9095
Sophia O ThomasSchool of Nursing and Health Studies, University of Miami, Coral Gables, Florida, United States of America.
Natalia VillegasSchool of Nursing, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Nilda Peragallo-MontanoSchool of Nursing, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
University of Miami · USUniversity of North Carolina at Chapel Hill · USPontificia Universidad Católica de Chile · CL

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWENDOLYN Barbara SCOTT · 2007 to 2026
$33.8M
NIAID NIH HHS P30 AI073961
6 · The paper itself

Abstract

The HIV epidemic disproportionately affects Hispanics in the U.S., with Hispanic women (HW) accounting for 18% of new HIV diagnoses in 2019 despite comprising only 16% of the female population. The imbalance of power related to cultural values and HW's lack of knowledge and low perception of risk for HIV interferes with prevention efforts (e.g., condom use, HIV testing, and Pre-Exposure Prophylaxis [PrEP]). It is estimated that in 2019, only 10% of women in the U.S. who could benefit from PrEP were given prescriptions for it. This number is estimated to be significantly lower among HW. PrEP is highly effective for preventing HIV, reducing the risk of acquiring HIV from sexual activity by about 99%. To respond to this need, we developed SEPA+PrEP, a biobehavioral HIV prevention intervention that adapted and integrated SEPA (Salud/Health, Educación/Education, Prevención/Prevention, Autocuidado/Self-Care), an empirically validated behavioral HIV prevention intervention, with the evidence-based biomedical strategy of PrEP. This study aimed to investigate the feasibility and acceptability of SEPA+PrEP among cisgender heterosexual Hispanic women (HW). We used a mixed methods approach to gather data from 44 HW living in the City of Homestead and its surrounding communities in Miami-Dade County, Florida. None of the participants knew about PrEP prior to participating in the study, and the majority (70.5%, n = 23) had not used condoms when engaging in vaginal sex during the previous three months. Overall, study results suggest that SEPA+PrEP is an acceptable and feasible intervention to prevent HIV among HW, with a focus on PrEP knowledge, initiation, and maintenance.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisFeasibility StudiesFemaleHeterosexualityHispanic or LatinoHumansAnti-HIV Agents

Identifiers

PMID38165906
PMCPMC10760780
OpenAlexW4390496293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.